Galderma Completes $1.5 Billion Acquisition of ZO Skin Health
What happened
Galderma announced the acquisition of ZO Skin Health for an enterprise value of $1.5 billion.
The Context
- Expansion of Portfolio: This acquisition enhances Galderma's premium skincare offerings, complementing its existing Alastin brand.
- Market Growth: ZO Skin Health has seen significant revenue growth, increasing from $140 million to over $330 million since Blackstone's investment in 2020.
- Future Investments: Galderma plans to ramp up commercial investments post-acquisition to drive growth in the physician-dispensed segment.
The Number
— This figure represents ZO Skin Health's net sales for the twelve months ending June 30, 2026, highlighting the brand's strong market position.
Takeaway
Expect Galderma to leverage this acquisition to enhance its market share and innovate within the skincare sector.
U.S. business news, corporate developments, and economy.
"The Wall Street Journal is respected for deep financial and economic reporting with a center-right editorial perspective."
— A47 Editor
Galderma to Buy ZO Skin Health for $1.5 Billion
Galderma has agreed to acquire ZO Skin Health for approximately $1.5 billion from its shareholders, including the Obagi family and funds managed by Blackstone Tactical Opportunities. This acquisition is part of Galderma's strategy to enhance its pres...
Market-moving headlines impacting equities, bonds, and related risk assets.
"Real-time catalysts and volatility drivers across indices and sectors."
— A47 Editor
Galderma to buy Zo Skin from Blackstone for $1.5 bln, Reuters reports
Galderma has announced its intention to acquire Zo Skin from Blackstone for $1.5 billion, as reported by Reuters. This acquisition is part of Galderma's strategy to expand its portfolio in the skincare market.
Market-moving headlines impacting equities, bonds, and related risk assets.
"Real-time catalysts and volatility drivers across indices and sectors."
— A47 Editor
Exclusive-Galderma agrees to buy ZO Skin Health for around $1.5 billion, sources say
Galderma has agreed to acquire ZO Skin Health for approximately $1.5 billion, a move that underscores its commitment to expanding its presence in the skincare market. This acquisition is expected to enhance Galderma's product offerings and market rea...